Biopôle Lausanne logo

Biopôle Lausanne

Biopôle is a life sciences Campus based in Lausanne, Switzerland, bringing together a strong community of industry and academia. It offers a world-class combination of infrastructure, added value services, living space and community engagement where partners can thrive and bring science to life. Biopôle works with both industry and academia to ensure that there is communal knowledge and appreciation of what projects they are pursuing and where there might be opportunities for synergies and collaboration. Biopôle SA, the management and promotion organisation for the park, was established in 2004 as a limited company by the public authorities of the Canton of Vaud. The organisation is led by an executive team and Board of Directors with an extensive track-record in life sciences.

Growth Trajectory

Biopôle is expanding its campus with new buildings planned for 2025 and is actively supporting companies in entering new markets like the US, UK, and EU. The organization is focused on fostering innovation in areas like AI-driven healthcare, digital health, and personalized medicine, which positions them for continued growth and attraction of new life science companies.

Technical Challenges

Tech Stack

Team Size

Key Risks

Competition in attracting and retaining innovative life science companies.
Navigating the complex regulatory requirements for medical devices and healthcare solutions.
Maintaining a leading position among global life science ecosystems, given increasing competition and investment in other hubs.
Dependence on external funding and investment for supporting startup companies.
Potential market volatility in the life sciences sector affecting investment and company growth.

Opportunities

Expanding campus infrastructure to attract more companies and corporate partners.
Leveraging partnerships with research institutions, hospitals, and corporate partners to enhance innovation.
Focusing on emerging fields like digital health, AI-driven healthcare, and personalized medicine to capture new market segments.
Offering more specialized programs and facilities tailored to specific areas within life sciences, such as cell and gene therapy.
Extending services to support companies in navigating regulatory pathways and securing market access in different regions.
Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats